Cirrhosis

Cirrhosis is advanced scarring of the liver after years of ongoing injury. Common causes include viral hepatitis B or Cmetabolic/fatty liver diseasealcohol-related liver diseaseautoimmune conditions, and genetic disorders such as hemochromatosis or alpha-1 antitrypsin deficiency.

A proactive testing plan uses blood and urine labs to check liver injuryliver function, and complications, and to help uncover the cause. Core tests assess enzymes (injury pattern), synthetic function (albumin, INR), cholestasis (alkaline phosphatase, GGT, bilirubin), and safety (sodium, creatinine). Add hepatitis panels and autoimmune/genetic work-upswhen indicated, and use lab-based fibrosis scores to estimate risk. Labs support screeningdiagnosisstaging, and monitoring, but they do not replace a clinician’s exam, ultrasound/elastography, or endoscopy when needed.

Signs, Symptoms & Related Situations

  • Often early and silent: normal daily life with abnormal labs only

  • Skin/eyes & digestion: jaundice, dark urine, pale stools, itchy skin, poor appetite, nausea

  • Abdomen & fluid: bloating or ascites (fluid in belly), rapid weight change, leg swelling

  • Bleeding/energy: easy bruising, nose/gum bleeding, fatigue, weakness

  • Thinking changes: sleep reversal, trouble concentrating, confusion (possible encephalopathy)

  • Risk contexts: heavy alcohol use, viral hepatitis exposure, metabolic syndrome (central weight gain, diabetes, high triglycerides), family history of iron or copper disorders, autoimmune disease

  • Seek urgent care now: vomiting blood or black stools, severe abdominal swelling with pain/fever, confusion or drowsiness, chest pain, or trouble breathing

All symptoms require evaluation by a qualified clinician.

Why These Tests Matter

What testing can do

  • Show how inflamed or obstructed the liver is (enzyme and cholestasis patterns)

  • Gauge how well the liver works (albumin, INR) and overall safety (sodium, creatinine) used in scores such as MELD

  • Help identify causes (hepatitis B/C, autoimmune markers, iron/copper/A1AT)

  • Track trends to guide follow-up and timing of imaging or specialist care

What testing cannot do

  • Prove cirrhosis on its own—imaging or elastography (and occasionally biopsy) may be needed

  • Replace ultrasound-based surveillance for liver cancer (HCC) or endoscopy for varices when indicated

  • Offer treatment or dosing advice—review all results with your clinician

What These Tests Measure (at a glance)

  • Liver enzymes (AST, ALT): reflect hepatocellular injury; higher values suggest active inflammation.

  • Cholestasis enzymes (Alkaline Phosphatase, GGT): rise with bile flow blockage or cholestatic disease.

  • Bilirubin (total/direct): processing of bile pigment; higher levels cause jaundice and can signal worsening function.

  • Albumin: made by the liver; low suggests reduced synthetic function or chronic inflammation.

  • PT/INR: blood-clotting proteins made by the liver; high INR indicates lower synthetic function.

  • Platelet count & CBC: low platelets often track with portal hypertension; CBC gives anemia/infection context.

  • Basic metabolic panel (sodium, creatinine/eGFR): key for MELD-type risk estimates and overall safety.

  • Hepatitis panels: HBsAg/anti-HBc/anti-HBsHCV antibody with reflex RNA.

  • Autoimmune & cholestatic markers: ANAASMAAMAIgG/IgM when patterns suggest autoimmune hepatitis or primary biliary cholangitis.

  • Iron & genetic context: Ferritiniron/TIBCtransferrin saturation (hemochromatosis risk); alpha-1 antitrypsin level/phenotypeceruloplasmin (Wilson disease).

  • Metabolic risk labs: A1clipid panel for fatty liver risk.

  • Fibrosis estimation (from routine labs): FIB-4 (age, AST, ALT, platelets), APRI (AST/platelets); ELF score where available.

  • HCC markers (context): AFP (± AFP-L3% / DCP where used) to complement ultrasound in surveillance programs.

Quick Build Guide

Clinical goal Start with Add if needed
Abnormal liver tests / suspected chronic liver disease Comprehensive liver panel (AST/ALT, ALP, GGT, bilirubin, albumin) • PT/INR • CBC • BMP (Na, creatinine) Hepatitis B/C panels • Iron studies • A1AT • Ceruloplasmin • ANA/ASMA/AMA • A1c/Lipids
Fatty liver risk (metabolic syndrome) Liver panel • Platelets • Albumin • A1c • Lipids Calculate FIB-4/APRI; consider ELFwhere available; rule out HBV/HCV
Cholestatic pattern (ALP/GGT high) Liver panel • Bilirubin fractions AMA • IgM (PBC context); clinician may add imaging
Monitoring known cirrhosis Bilirubin • INR • Creatinine • Sodium • Albumin • Platelets AFP for HCC surveillance; trend MELD-type labs
Unclear cause Liver panel • PT/INR • CBC Hepatitis panels • Autoimmune markers • Iron/A1AT/Ceruloplasmin per findings

How the Testing Process Works

  1. Choose your starting set: most people begin with a comprehensive liver panelPT/INRCBC, and BMP(sodium, creatinine).

  2. Add cause testing: order hepatitis panels and autoimmune/genetic labs based on patterns and history.

  3. Collection & timing: standard blood draw; fasting only if lipids are included. Avoid heavy alcohol the day before testing when possible.

  4. Results & access: results post to your secure account, typically in a few days.

  5. Next steps: review with your clinician; imaging (ultrasound/FibroScan/MRI) or endoscopy may be advised. Repeat at set intervals to track trends.

Interpreting Results (General Guidance)

  • Hepatocellular pattern: high AST/ALT with normal/mildly high ALP suggests liver cell injury.

  • Cholestatic pattern: high ALP ± GGT with variable AST/ALT points to bile-flow problems or cholestatic disease.

  • Falling albumin / rising INR / rising bilirubin: reduced synthetic function—often a sign of advancing disease.

  • Low platelets: may indicate portal hypertension; correlate with imaging and exam.

  • Hyponatremia or rising creatinine: worsening circulatory/renal status—requires prompt clinical attention.

  • FIB-4/APRI high: suggests advanced fibrosis; confirm with elastography or specialist guidance.
    Always interpret results with a qualified healthcare professional; patterns and trends matter more than any single value.

Choosing Panels vs. Individual Tests

  • Foundational liver set (most users): Liver panel • PT/INR • CBC • BMP (Na, creatinine)

  • Etiology work-up: Hepatitis B/C panels • ANA/ASMA/AMA • Iron studies • A1AT • Ceruloplasmin

  • Fibrosis staging: calculate FIB-4/APRI from routine labs; add ELF where available; imaging/elastography remains key

  • Monitoring known cirrhosis: repeat bilirubin, INR, creatinine, sodium, albumin, platelets and add AFP per surveillance plans

FAQs

Can blood tests diagnose cirrhosis by themselves?
No. Labs suggest cirrhosis and its severity, but ultrasound or elastography (and sometimes biopsy) confirm stage.

Do I need to fast?
Not for standard liver tests. Fast only if your order includes lipids.

What is MELD and how is it used?
It’s a risk score that uses bilirubin, INR, creatinine, and sodium to estimate disease severity. Your clinician calculates and interprets it.

Why are my platelets low?
Low platelets can reflect portal hypertension and spleen enlargement common in advanced scarring.

Are AFP tests enough for liver cancer screening?
No. Ultrasound is the cornerstone; AFP can support surveillance but does not replace imaging.

Can labs be normal if I have cirrhosis?
Yes—especially in compensated disease. That’s why periodic testing and imaging are important.

Should I stop alcohol before testing?
Avoid alcohol before labs and discuss your use with your clinician; alcohol can alter results and disease risk.

Related Categories & Key Tests

  • Liver & Gallbladder Tests Hub

  • Hepatitis B & C Tests • Fatty Liver (Metabolic) • Autoimmune Liver Disease • Hemochromatosis Tests • Wilson’s Disease Tests • General Health Panels

  • Key Tests: AST • ALT • Alkaline Phosphatase • GGT • Total/Direct Bilirubin • Albumin • PT/INR • Platelets & CBC • Sodium • Creatinine/eGFR • Hepatitis B panel • HCV Ab ± RNA • ANA • ASMA • AMA • IgG/IgM • Ferritin • Iron/TIBC • Transferrin Saturation • Alpha-1 Antitrypsin Level/Phenotype • Ceruloplasmin • A1c • Lipid Panel • FIB-4/APRI (calculated) • ELF (where available) • AFP

References

  • American Association for the Study of Liver Diseases (AASLD) — Practice Guidance on Cirrhosis and Portal Hypertension.
  • AASLD — Guidance on Hepatocellular Carcinoma Surveillance.
  • AASLD — Guidance on Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD/NAFLD).
  • European Association for the Study of the Liver (EASL) — Clinical Practice Guidelines on Decompensated Cirrhosis.
  • World Health Organization — Hepatitis B and C Testing Guidelines.
  • Clinical reviews on noninvasive fibrosis scores (FIB-4, APRI, ELF) and laboratory monitoring in cirrhosis.

Available Tests & Panels

Your Cirrhosis Tests menu is pre-populated in the Ulta Lab Tests system. Start with a comprehensive liver panelPT/INRCBC, and BMP (sodium, creatinine). Use filters to add hepatitis panelsautoimmune/genetic work-ups, and fibrosis scoring support. Review results with your clinician to plan imaging, surveillance, and follow-up.

  • Page
  • 1
  • of
  • 3
  • Total Rows
  • 54
Name Matches

The Comprehensive Metabolic Panel (CMP) Test measures 21 markers to assess metabolic health, liver and kidney function, and electrolyte balance. It includes glucose, calcium, sodium, potassium, chloride, CO2, albumin, globulin, A/G ratio, total protein, bilirubin, ALP, AST, ALT, BUN, creatinine, BUN/creatinine ratio, and eGFR. The CMP helps detect diabetes, liver or kidney disease, and supports routine screening and chronic condition monitoring.

Blood
Blood Draw
Also Known As: CMP Test, Chemistry Panel Test, Chem Test, Chem 21 Test, Chem 14 Test 

The Hepatic Function Panel Test measures liver enzymes, proteins, and bilirubin to assess liver health and function. It includes ALT, AST, ALP, albumin, total protein, and bilirubin levels. Abnormal results may indicate hepatitis, cirrhosis, fatty liver, or bile duct problems. Doctors use this test to investigate jaundice, nausea, abdominal pain, or fatigue and to monitor liver disease, alcohol use, or medication side effects affecting liver function.

Blood
Blood Draw
Also Known As: Liver Function Panel Test, LFT

The Liver Function Panel, also known as a Hepatic Function Panel, measures proteins, enzymes, and bilirubin to assess liver health and function. It helps detect liver disease, monitor liver conditions, and evaluate the effects of medications or other factors on liver performance.

Blood
Blood Draw
Also Known As: Hepatic Function Panel Test, HFP Test

The Complete Blood Count with Differential and Platelets Test is a comprehensive blood test that checks red blood cells, white blood cells, hemoglobin, hematocrit, and platelets. The differential analyzes types of white blood cells to detect infections, anemia, clotting abnormalities, immune conditions, and certain cancers. This essential test is often ordered for routine health exams, diagnosis, and monitoring treatment progress.

Blood
Blood Draw
Also Known As: CBC Test, CBC with Differential and Platelets Test, CBC w/Diff and Platelets Test, Full Blood Count Test, Complete Blood Count Test

The Prothrombin Time with INR Test measures how long it takes blood to clot and calculates the international normalized ratio (INR) for accuracy. It is commonly used to monitor patients on blood-thinning medications like warfarin and to evaluate bleeding disorders, liver disease, or vitamin K deficiency. Doctors order this test to investigate easy bruising, frequent nosebleeds, or prolonged bleeding and to ensure safe and effective anticoagulant therapy.

Blood
Blood Draw
Also Known As: PT with INR Test

The Prothrombin with INR and Partial Thromboplastin Times Test measures how long blood takes to clot by evaluating PT, INR, and aPTT. Abnormal results may indicate clotting disorders, liver disease, vitamin K deficiency, or risk of bleeding and thrombosis. Doctors use this test to monitor patients on blood thinners like warfarin, assess unexplained bleeding, and evaluate clotting function. It provides critical insight into coagulation and overall blood health.

Also Known As: PT with INR and aPTT Test, PT/INR and PTT Test

The Activated Partial Thromboplastin Time (aPTT) Test measures how long it takes blood to clot, evaluating clotting factors and overall coagulation function. Abnormal results may indicate bleeding disorders, hemophilia, liver disease, or clotting factor deficiencies. Doctors also use this test to monitor patients on heparin therapy. Results provide essential insight into blood clotting, bleeding risk, and treatment management for safe medical care.

Blood
Blood Draw
Also Known As: aPTT Test, PTT Test

The Iron Total and Total Iron Binding Capacity (TIBC) Test measures iron levels in blood along with the blood’s ability to transport iron. It helps diagnose iron deficiency anemia, iron overload (hemochromatosis), and monitor nutritional or chronic health conditions. Low iron or high TIBC may indicate anemia, while high iron or low TIBC can suggest overload. Doctors use this test to evaluate fatigue, weakness, or other symptoms linked to iron and metabolic health.

Blood
Blood Draw
Also Known As: Serum Iron Test, Total Iron Binding Capacity Test, TIBC Test, UIBC Test

The Alpha-1-Antitrypsin Quantitative Test measures levels of alpha-1-antitrypsin (AAT), a protein that protects the lungs and liver from damage. Low levels may indicate alpha-1-antitrypsin deficiency, a genetic disorder linked to emphysema, COPD, and liver disease. Doctors use this test to investigate unexplained lung or liver problems, confirm hereditary AAT deficiency, and guide treatment or monitoring strategies for long-term health management.

Blood
Blood Draw
Also Known As: Alpha-1 Antitrypsin Test, A1AT Test, AAT Test, Alpha-1 Antitrypsin Serum Test

The Actin Smooth Muscle IgG Antibody Test detects autoantibodies against smooth muscle actin, often linked to autoimmune hepatitis and chronic liver disease. Elevated levels may indicate liver inflammation, cirrhosis, or other autoimmune conditions. Doctors use this blood test with liver panels and additional antibody tests to aid in diagnosis, monitor disease progression, and guide treatment decisions for patients with suspected autoimmune liver disorders.

Blood
Blood Draw
Also Known As: Actin IgG Antibody Test

The Copper Micronutrient Plasma Test measures copper levels in the blood to evaluate nutritional status and detect deficiencies or excess. Copper is essential for red blood cell formation, connective tissue health, energy production, and nervous and immune system function. This test helps identify imbalances from poor diet, malabsorption, or toxicity, supporting diagnosis and management of overall health.

Patient must be 18 years of age or older.
Blood
Blood Draw

Most Popular

The Copper Test measures copper levels in blood to evaluate nutritional status, liver function, and metabolic health. Abnormal levels may indicate Wilson’s disease, Menkes disease, liver disorders, or malnutrition. Both deficiency and excess copper can affect nervous system, immune function, and energy metabolism. Doctors use this test to investigate unexplained symptoms, monitor treatment, or assess copper-related disorders, providing key insight into overall health.

Blood
Blood Draw
Also Known As: Cu Test, Copper Serum Test, Copper Plasma Test

The Copper 24 Hour Urine Test evaluates copper elimination in urine across a full day, helping identify metabolic or liver-related disorders. Abnormal levels may signal Wilson’s disease, copper toxicity, or deficiency. By capturing copper output over 24 hours, the test provides insight into copper balance, aiding in the assessment of hepatic function, nutritional status, and the effects of excessive copper exposure.

Urine
Urine Collection

The Copper RBC Test measures copper levels inside red blood cells, reflecting long-term copper status and cellular availability. Unlike serum copper, which can fluctuate, RBC copper gives a more accurate picture of tissue stores. Abnormal results may indicate copper deficiency, malnutrition, malabsorption, Wilson’s disease, or excess copper exposure. Doctors use this test to evaluate metabolic health, monitor treatment, and support diagnosis of mineral imbalances.

Blood
Blood Draw
Also Known As: Cu RBC Test, Cu Test, Blood Copper Test, RBC Copper Test, Hepatic Copper Test, Copper Blood Test

The Mitochondria M2 IgG Antibody Test measures antibodies linked to autoimmune liver disease, particularly primary biliary cholangitis. These antibodies target mitochondrial enzymes in liver cells, helping to identify immune-related causes of chronic liver dysfunction. Providers use this test when investigating persistent fatigue, elevated liver enzymes, or suspected autoimmune involvement in bile duct damage.

Blood
Blood Draw

The Mitochondrial Antibody with Reflex to Titer Test detects antimitochondrial antibodies (AMAs), most commonly linked to primary biliary cholangitis (PBC), an autoimmune liver disease. If antibodies are present, reflex titers measure their level for greater diagnostic detail. Doctors use this test to investigate unexplained liver abnormalities, chronic fatigue, or jaundice, helping confirm autoimmune liver disease and guide long-term management.

Blood
Blood Draw

The Alpha-Fetoprotein (AFP) and AFP-L3 Test measures total AFP and the AFP-L3 fraction, which is more specific for liver cancer risk. Elevated AFP may indicate liver disease, germ cell tumors, or hepatitis, while AFP-L3 is strongly associated with hepatocellular carcinoma (HCC). Doctors order this test to assess liver function, screen high-risk patients, and monitor cancer treatment. Results provide critical insight into liver health and cancer detection.

Blood
Blood Draw
Also Known As: AFP Test, Total AFP Test, Alpha-Fetoprotein Tumor Markers, Alpha-Fetoprotein Test

The Ammonia Plasma Test measures ammonia levels in blood to evaluate liver function and metabolic health. Elevated ammonia may result from liver disease, cirrhosis, Reye’s syndrome, or urea cycle disorders, causing confusion or altered mental status. Doctors order this test for patients with unexplained behavioral changes, lethargy, or suspected hepatic encephalopathy. Results provide key insight into liver function, metabolic disorders, and treatment monitoring.

Blood
Blood Draw
Also Known As: NH3 Test, NH3 Plasma Test, Ammonia Blood Test

The Albumin Test measures albumin, the main protein made by the liver that maintains fluid balance and transports hormones, vitamins, and medications. Low albumin may indicate liver disease, kidney problems, malnutrition, or chronic inflammation, while high levels may reflect dehydration. Doctors order this test to evaluate swelling, fatigue, or abnormal labs. Results provide key insight into nutritional status, liver and kidney function, and overall metabolic health.

Blood
Blood Draw
Also Known As: ALB Test

The ALP Test measures alkaline phosphatase enzyme levels in blood to evaluate liver, bone, and bile duct health. High ALP may indicate liver disease, bile duct obstruction, bone disorders, or certain cancers, while low levels may suggest malnutrition or deficiency. Doctors order this test to investigate symptoms like fatigue, abdominal pain, or bone pain and often pair it with other liver function tests. Results provide key insight into metabolic and organ health.

Blood
Blood Draw
Also Known As: Alkaline Phosphatase Test, Alk Phos Test, Alkp Test

The ALT Test measures alanine aminotransferase, an enzyme mainly found in the liver. Elevated ALT may indicate liver damage from hepatitis, fatty liver disease, cirrhosis, alcohol use, or medication effects. Doctors order this test to evaluate symptoms such as fatigue, abdominal pain, or jaundice and often pair it with AST for accurate liver assessment. Results provide essential insight into liver health, enzyme activity, and overall metabolic function.

Blood
Blood Draw
Also Known As: Alanine Aminotransferase Test, GPT Test, SGPT Test, Serum Glutamic Pyruvic Transaminase Test

The AST Test measures aspartate aminotransferase, an enzyme found in the liver, heart, muscles, and other tissues. Elevated AST may indicate liver disease, heart attack, muscle injury, or other organ damage. Doctors order this test to evaluate symptoms such as fatigue, weakness, or jaundice and often pair it with ALT for accurate liver assessment. Results provide key insight into liver function, muscle health, and overall metabolic balance.

Blood
Blood Draw
Also Known As: Aspartate Aminotransferase Test, Serum Glutamic-Oxaloacetic Transaminase Test, SGOT Test

Most Popular

The B-Type Natriuretic Peptide (BNP) Test measures BNP levels in blood to help diagnose and monitor heart failure and other cardiac conditions. High levels suggest the heart is under stress, often from congestive heart failure, hypertension, or heart disease. Doctors order this test for patients with shortness of breath, fatigue, or swelling. Results provide critical insight into heart function, guiding treatment and monitoring response to therapy.

Blood
Blood Draw
Also Known As: Brain Natriuretic Peptide Test

The Bilirubin Direct Test measures conjugated bilirubin in the blood to assess liver function and bile duct health. Elevated levels may indicate hepatitis, cirrhosis, gallstones, or bile duct obstruction, while low levels are generally normal. Doctors order this test for patients with jaundice, fatigue, or suspected liver disease. Results help diagnose and monitor liver disorders, guide treatment decisions, and evaluate overall hepatic and biliary health.

Blood
Blood Draw
Also Known As: Direct Bilirubin Test

The Fractionated Bilirubin Test separates total bilirubin into direct and indirect forms to assess liver and blood health. Elevated direct bilirubin may point to hepatitis, cirrhosis, or bile duct obstruction, while elevated indirect levels can signal hemolytic anemia or inherited disorders. Doctors order this test for jaundice, anemia, or suspected liver conditions. Results help guide diagnosis, treatment, and monitoring of liver and blood disorders.

Blood
Blood Draw
Also Known As: Fractionated Bilirubin Test

Cirrhosis occurs when healthy liver tissue gets damaged over a long period of time. Chronic liver disease leads to scarring of liver tissue, which affects the structure and functionality of the liver. Cirrhosis is linked to over 32,000 annual deaths in the United States alone.  

A wide variety of chronic liver conditions could be responsible for cirrhosis. It takes years or even decades to develop the condition. Compared to scars that occur in most of the other parts of the body, liver scarring is reversible – even in patients with cirrhosis. The liver is located on the upper right-hand side of your abdomen and is a vital organ in the body. It converts nutrients from food into vital blood components, metabolizes, detoxifies, and produces many factors that are necessary for blood clotting. The liver also produces bile for the digestion of fats. 

Liver disease can affect all these functions. Liver disease can occur due to a wide variety of causes such as physical injuries, infections, autoimmune conditions, exposure to toxins, and genetic conditions that lead to the build-up of iron and copper. Liver disease can lead to inflammation, clotting abnormalities, obstruction of bile flow, and many other conditions. Persistent or prolonged damage to the liver results in accumulating excess connective tissue or fibrosis of the liver – which can lead to cirrhosis at a later stage.  

When one has cirrhosis, the structure of his/her liver will change – forming nodules of cells that are surrounded by fibrous tissue. Fibrous tissue won’t function like healthy liver tissue. It will interfere with the flow of bile and blood through the liver. Cirrhosis begins to affect many other organs and tissues throughout the body as the condition progresses. Some examples of cirrhosis complications include: 

  • Portal Hypertension – The pressure increases in the vein that carries blood to the liver.  
  • Swelling and bleeding of veins in the esophagus or stomach – this happens because of the increased pressure due to portal hypertension and the redirection of blood into the smaller veins. 
  • Increasing of blood toxins – which can lead to confusion and many other mental changes. 
  • Kidney disfunction 
  • Fluid build-up in the abdomen – Ascites 
  • Easy bleeding and bruising due to the decline in the production of clotting factor. 
  • Patients who suffer from cirrhosis are at a higher risk of developing liver cancer over time – about 3-5% of cirrhosis patients are supposed to get multiple cancers, including liver cancer in the long run. 

Causes:

When injury or damage to the liver is limited, it can repair itself. But when injury or damage is repeated over many years, it will result in liver cirrhosis.

There are many causes of liver cirrhosis, but they fall into one of these categories: 

  • Excessive use of alcohol over time can lead to alcoholic liver cirrhosis in the long run. 
  • Hepatitis conditions such as viral hepatitis, nonalcoholic fatty liver disease (NAFLD), and autoimmune hepatitis 
  • Damage to bile ducts or biliary obstruction 
  • Congestive heart failure can result in liver damage and cirrhosis in the long run. 
  • Drug and toxin-related conditions 
  • Metabolic or inherited conditions such as hemochromatosis, cystic fibrosis, and Wilson disease 
  • In about 10% of cirrhosis cases, the actual cause is unknown. 

The causes of liver cirrhosis may vary by population or geographic region. Over 50% of the cases in the United States are caused due to alcoholism or chronic hepatitis C infection. Chronic hepatitis B infection coupled with hepatitis D co-infection leads to a significant number of cirrhosis cases in other parts of the world. Nonalcoholic steatohepatitis (NASH) and nonalcoholic fatty liver disease (NAFLD) are two of the most common causes of non-infectious cirrhosis. The frequency of this cause is increasing across the globe. 

Symptoms of Liver Cirrhosis 

Most people who suffer from the condition don’t have or have little clinical evidence of the disease. Symptoms don’t usually occur until significant scarring of the liver has occurred. Some of the symptoms of the condition include: 

  • Weakness 
  • Fatigue 
  • Confusion and difficulty in concentrating 
  • Itching 
  • Abdominal discomfort 
  • Jaundice 
  • Abdominal swelling due to ascites or build-up of fluid in the abdomen 
  • Leg swelling 
  • Easy bruising and bleeding 
  • Nausea 
  • Loss of appetite and weight loss 

Tests 

Cirrhosis needs to be diagnosed as soon as possible to have a chance of saving the life of the patient. If not, significant liver damage could occur with little or no clinical evidence of the condition. When the cause of the liver disease is controlled or eliminated, the scarring will stop, and some existing scars may resolve. There isn’t a specific test to diagnose liver cirrhosis. But blood tests can help detect liver injury. A liver biopsy is the best test to diagnose cirrhosis. But the procedure is invasive and won’t detect every case. 

Routine laboratory tests can help detect liver damage or scarring. These tests can help evaluate the severity of the condition in case the patient has some risk factors of developing cirrhosis. The patient may need additional tests to diagnose the underlying cause of the condition and monitor his or her health in the long run. It includes monitoring the development of hepatocellular carcinoma. 

Routine Tests 

Liver injury is usually diagnosed by a liver panel or a comprehensive metabolic panel (CMP).

Here are some tests included in these panels: 

  • Aspartate aminotransferase (AST) – AST is an enzyme found in the liver and many other organs in the body. AST will be elevated if a person has a liver injury or cirrhosis. 
  • Alanine aminotransferase (ALT) – This enzyme is found mainly in the liver. The values will be increased when a person has a liver disease or cirrhosis. 
  • Alkaline phosphatase (ALP) – ALP is an enzyme found in the bile ducts. When one has cirrhosis, ALP can be normal or mildly elevated.  
  • Total bilirubin – Bilirubin is produced exclusively in the liver. It increases with most liver conditions. Bilirubin is either normal or slightly increased until cirrhosis becomes advanced. 
  • Albumin – This is a protein made by the liver and decreases when one has cirrhosis. 

If any of these test results are abnormal, one needs to further investigate the cause of it. The pattern of results will be more informative than any single test. 

Complete Blood Count or CBC – This test is ordered to evaluate the red and white blood cells and platelets. Anemia can occur if bleeding has occurred. Platelets become decreased when one has cirrhosis. 

Prothrombin Time (PT/INR) – Most of the clotting factors are produced in the liver. This test is important to evaluate the clotting function. The results can be prolonged with cirrhosis. 

These tests are used to monitor the progression of cirrhosis. As the condition progresses, the results can become increasingly abnormal.  

Additional Testing 

If a patient has chronic liver disease, the healthcare provider will order hepatitis C and B testing to determine the underlying cause of the condition. If ascites is present, your healthcare provider will order a peritoneal fluid analysis test. A liver biopsy is done to diagnose the cause of the condition. It involves taking a sample of liver tissue to evaluate the structure and cells of the liver. A biopsy will clearly indicate the presence of cirrhosis. But since the sample is tiny, a negative result cannot rule out cirrhosis. Depending on the situation, one or more of these specialized tests may be performed: